These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10735971)

  • 1. The treatment of atopic dermatitis with adjunctive high-dose intravenous immunoglobulin: a report of three patients and review of the literature.
    Jolles S; Hughes J; Rustin M
    Br J Dermatol; 2000 Mar; 142(3):551-4. PubMed ID: 10735971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of high-dose intravenous immunoglobulin treatment for atopic dermatitis.
    Jolles S
    Clin Exp Dermatol; 2002 Jan; 27(1):3-7. PubMed ID: 11952659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dermatological uses of high-dose intravenous immunoglobulin.
    Jolles S; Hughes J; Whittaker S
    Arch Dermatol; 1998 Jan; 134(1):80-6. PubMed ID: 9449914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High dose intravenous immunoglobulin in atopic dermatitis and hyper-IgE syndrome.
    Wakim M; Alazard M; Yajima A; Speights D; Saxon A; Stiehm ER
    Ann Allergy Asthma Immunol; 1998 Aug; 81(2):153-8. PubMed ID: 9723561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjunctive high-dose intravenous immunoglobulin treatment for resistant atopic dermatitis: efficacy and effects on intracellular cytokine levels and CD4 counts.
    Jolles S; Sewell C; Webster D; Ryan A; Heelan B; Waite A; Rustin M
    Acta Derm Venereol; 2003; 83(6):433-7. PubMed ID: 14690338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous immunoglobulin therapy for the treatment of severe atopic dermatitis.
    Lamb SR; Rademaker M
    Expert Opin Pharmacother; 2001 Jan; 2(1):67-74. PubMed ID: 11336569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smallpox vaccination and adverse reactions. Guidance for clinicians.
    Cono J; Casey CG; Bell DM;
    MMWR Recomm Rep; 2003 Feb; 52(RR-4):1-28. PubMed ID: 12617510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous immune globulin (i.v.IG) therapy in steroid-resistant atopic dermatitis.
    Noh G; Lee KY
    J Korean Med Sci; 1999 Feb; 14(1):63-8. PubMed ID: 10102526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating the Efficacy and Anti-infective Effect of High-dose Intravenous Immunoglobulin Adjuvant Therapy for Acquired Aplastic Anemia Children.
    Bian Z; Zhou N; Qiao X; Lu S; Song X; Zhou H
    J Pediatr Hematol Oncol; 2019 Mar; 41(2):129-132. PubMed ID: 30339655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous immunoglobulin to treat severe atopic dermatitis in children: a case series.
    Turner PJ; Kakakios A; Wong LC; Wong M; Campbell DE
    Pediatr Dermatol; 2012; 29(2):177-81. PubMed ID: 22085141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes of serum levels of interleukin-2, intercellular adhesion molecule-1, endothelial leukocyte adhesion molecule-1 and Th1 and Th2 cell in severe atopic dermatitis after intravenous immunoglobulin therapy.
    Huang JL; Lee WY; Chen LC; Kuo ML; Hsieh KH
    Ann Allergy Asthma Immunol; 2000 Mar; 84(3):345-52. PubMed ID: 10752921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Exfoliative dermatitis as a side effect of intravenous immunoglobulin treatment].
    Markvardsen LH; Jakobsen J
    Ugeskr Laeger; 2011 Oct; 173(43):2725-6. PubMed ID: 22027232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical dose and adverse effects of topical steroids in daily management of atopic dermatitis.
    Furue M; Terao H; Rikihisa W; Urabe K; Kinukawa N; Nose Y; Koga T
    Br J Dermatol; 2003 Jan; 148(1):128-33. PubMed ID: 12534606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preliminary estimation of results of high-dose intravenous immunoglobulin in severe steroid-dependent adult asthma].
    Kłos K; Kruszewski J
    Pol Merkur Lekarski; 2001 Nov; 11(65):379-83. PubMed ID: 11852803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized controlled evaluator-blinded trial of intravenous immunoglobulin in adults with severe atopic dermatitis.
    Paul C; Lahfa M; Bachelez H; Chevret S; Dubertret L
    Br J Dermatol; 2002 Sep; 147(3):518-22. PubMed ID: 12207594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atopic dermatitis: skin-directed management.
    Tollefson MM; Bruckner AL;
    Pediatrics; 2014 Dec; 134(6):e1735-44. PubMed ID: 25422009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting IgE Antibodies by Immunoadsorption in Atopic Dermatitis.
    Kasperkiewicz M; Schmidt E; Ludwig RJ; Zillikens D
    Front Immunol; 2018; 9():254. PubMed ID: 29520268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunomodulation in the treatment of atopic dermatitis].
    Jílek D; Král V; Duchková H; Richter J
    Cas Lek Cesk; 1998 Jun; 137(13):397-9. PubMed ID: 9748732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of trial design in studies using high-dose intravenous immunoglobulin.
    Jolles S; Hughes J
    Br J Dermatol; 2003 Jun; 148(6):1284-5; author reply 1285-6. PubMed ID: 12828775
    [No Abstract]   [Full Text] [Related]  

  • 20. Experience with intravenous immunoglobulin in severe childhood atopic dermatitis.
    Ozen A; Baris S; Karakoc Aydiner E; Yucelten D; Nadir Bahceciler N
    Allergol Immunopathol (Madr); 2012; 40(2):131-3. PubMed ID: 21855202
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.